⚠️ RESEARCH USE ONLY - NOT FOR HUMAN CONSUMPTION - NOT APPROVED BY MHRA - 18+ ONLY

Verified Peptides

Tirzepatide Research & Scientific Studies

Explore the latest peer-reviewed research and scientific studies

About Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist used in metabolic research. Supplied as a lyophilized powder for laboratory studies investigating dual incretin receptor activation, insulin-related signaling pathways, and glucose homeostasis mechanisms in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.

Purity>95-99
Categorypeptide

Latest Research

Featured Study

Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission - a UK case study.

Annemans L et al.J Med Econ2026

Recent research on Tirzepatide: Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission - a UK case study.

Read Full Study on PubMed
Featured Study

Tirzepatide for weight and behavior management in a patient with Smith-Magenis syndrome.

Liao XC et al.JCEM Case Rep2026

Recent research on Tirzepatide: Tirzepatide for weight and behavior management in a patient with Smith-Magenis syndrome.

Read Full Study on PubMed

Additional Studies

DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model.

Sasset L et al.Mol Ther Nucleic Acids2026

Recent research on Tirzepatide: DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model.

Read on PubMed

Real-world and computational identification of herbal candidates associated with adverse event patterns in glucagon-like peptide-1 therapy for obesity.

Park J et al.Sci Rep2026

Recent research on Tirzepatide: Real-world and computational identification of herbal candidates associated with adverse event patterns in glucagon-like peptide-1 therapy for obesity.

Read on PubMed

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity.

Merola JF et al.Arthritis Rheumatol2026

Recent research on Tirzepatide: Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity.

Read on PubMed

Towards Sustainable Synthesis of Peptide Therapeutics via Tag-Assisted Peptide Synthesis and Aryl Selenoester Aminolysis Ligation.

Egelund PHG et al.J Am Chem Soc2026

Recent research on Tirzepatide: Towards Sustainable Synthesis of Peptide Therapeutics via Tag-Assisted Peptide Synthesis and Aryl Selenoester Aminolysis Ligation.

Read on PubMed

GLP-1-based therapy and ICD-10-documented heart failure or respiratory failure events in non-diabetic adults with rheumatoid arthritis and obesity: a TriNetX federated cohort study.

Loizidis G et al.Clin Rheumatol2026

Recent research on Tirzepatide: GLP-1-based therapy and ICD-10-documented heart failure or respiratory failure events in non-diabetic adults with rheumatoid arthritis and obesity: a TriNetX federated cohort study.

Read on PubMed

Use of second-generation incretin analogs (GLP-1 and GIP receptor agonists) in type 1 diabetes and latent autoimmune diabetes in adults: A systematic review.

Horne MP et al.J Am Assoc Nurse Pract2026

Recent research on Tirzepatide: Use of second-generation incretin analogs (GLP-1 and GIP receptor agonists) in type 1 diabetes and latent autoimmune diabetes in adults: A systematic review.

Read on PubMed

Related Research

Purchase Tirzepatide from Verified Peptides

High-purity research peptides with full analytical verification

  • 99% Purity (HPLC Verified)
  • Full Certificate of Analysis
  • Same Day Dispatch
  • Free UK Shipping Over £75
Buy Tirzepatide - 99% Purity, Same Day Dispatch

Research Disclaimer

The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.